ELAB - CIK 0001840563
The table below shows Elevai Labs Inc.'s cash flow statement line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating cash flow | -$5.93M | -$5.49M | -$4.56M | -$1.59M |
| Capital expenditure | $442.25K | $9.16K | $11.19K | - |
| Investing cash flow | -$2.77M | -$610.56K | -$11.19K | -$32.03K |
| Dividends paid | - | - | - | - |
| Stock buybacks | - | - | - | - |
| Financing cash flow | $10.12M | $6.76M |
Elevai Labs Inc. reported operating cash flow of -$5.93M for fiscal year 2025. That is down 8.1% from -$5.49M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $6.74M |
| $2.36M |